Physician profile
Maha Ahmad
NPI 1710193610
$38,279.60
in general payments reported to CMS, 2019-2025
10 companies · $4,767 in 2025
The $4,767 reported for 2025 was more than what 88% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,188 · 2021: $5,550 · 2023: $91.50 · 2025: $4,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,767 · Food and Beverage: $91.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,767.00 |
| Food and Beverage | $91.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22,525.09 | 2019-2020 | |
| Eisai INC. | $9,849.02 | 2019-2021 | |
| Imbrium Therapeutics L.P. | $4,767.00 | 2025 | |
| Merck Sharp & Dohme LLC | $869.99 | 2019 | |
| Jazz Pharmaceuticals INC. | $177.00 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $91.50 | 2023 | Ribfix Blu Advantage |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maha Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.